* USANA Health Sciences Inc USNA.N reported quarterly
adjusted
earnings of $1.15 per share for the quarter ended in March.
The mean expectation of three analysts for the quarter was
for earnings of $1.14 per share.
* Revenue fell 11.4% to $272.87 million from a year ago;
analysts
expected $267.32 million.
* USANA Health Sciences Inc's reported EPS for the quarter
was
$1.15.
* The mean earnings estimate of analysts had fallen by
about 14.9%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* USANA Health Sciences Inc shares had fallen by 0.9% this
quarter and lost 22.2% so far this year.
* The company reported quarterly net income of $22.47
million.
* Wall Street's median 12-month price target for USANA
Health
Sciences Inc is $93.00
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
This summary was machine generated April 26 at 08:56 p.m. All
figures in US dollars unless otherwise stated